Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,463 | -2,299 | -8,831 | -6,405 | -4,356 |
| Depreciation Amortization | 184 | 12 | 376 | 285 | 195 |
| Accounts receivable | -35 | -70 | N/A | N/A | N/A |
| Other Working Capital | 411 | -56 | 294 | -327 | -951 |
| Other Operating Activity | 47 | 73 | -31 | -9 | 18 |
| Operating Cash Flow | $-4,856 | $-2,340 | $-8,192 | $-6,456 | $-5,094 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -12 | -12 | N/A |
| Investing Cash Flow | $N/A | $N/A | $-12 | $-12 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 5,369 | 4,337 | N/A |
| Financing Cash Flow | $N/A | $N/A | $5,369 | $4,337 | $N/A |
| Beginning Cash Position | 7,100 | 7,100 | 9,935 | 9,935 | 9,935 |
| End Cash Position | 2,244 | 4,760 | 7,100 | 7,804 | 4,841 |
| Net Cash Flow | $-4,856 | $-2,340 | $-2,835 | $-2,131 | $-5,094 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,856 | -2,340 | -8,192 | -6,456 | -5,094 |
| Capital Expenditure | N/A | N/A | -12 | -12 | N/A |
| Free Cash Flow | -4,856 | -2,340 | -8,204 | -6,468 | -5,094 |